SRRK

Scholar Rock Holding CorporationNASDAQHealthcare

$50.01+1.34%ClosedMarket Cap: $5.75B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-04-01	Wedbush	—	Outperform	—
2026-03-16	JP Morgan	—	Overweight	—
2026-03-04	Truist Securities	—	Buy	—
2026-03-04	Citigroup	—	Buy	—
2026-03-04	Piper Sandler	—	Overweight	—
2026-03-04	BMO Capital	—	Outperform	—
2026-03-04	Barclays	—	Overweight	—
2026-03-03	HC Wainwright & Co.	—	Buy	—
2026-01-26	HC Wainwright & Co.	—	Buy	—
2025-12-17	Barclays	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-2.34	$175.6M	12
Sun Dec 31	$-1.24	$365.3M	9
Mon Dec 31	$-0.19	$595.2M	3
Tue Dec 31	$1.34	$868.9M	3